866-997-4948(US-Canada Toll Free)

Clarient, Inc. - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Oct 2012

Category :

Competitive Analysis

No. of Pages : 32 Pages


Clarient Inc. (Clarient) is a cancer diagnostic laboratory services provider with the focus on providing oncology testing and other diagnostics services. The company provides accurate and detailed information to characterize and assess cancer for accurate diagnosis and effective treatment. It offers its services to oncologists, pathologists, hospitals and bio-pharmaceutical companies. The company focuses on the most common types of solid tumors such as breast, ovarian, prostate, lung and colon. Clarient also develops new, proprietary companion diagnostic markers for therapeutics in breast, prostate, lung and colon cancers, and leukemia/ lymphoma. It is operating as a wholly-owned subsidiary of GE Healthcare Ltd. after its acquisition in December 21, 2010. The company operates in the US through its subsidiaries, Clarient is headquartered in Aliso Viejo in California, the US.

This report is a source for data, analysis and actionable intelligence on the Clarient, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4

Clarient, Inc. - Business Description 5

Key Facts 6
Clarient, Inc. - Major Products and Services 7
Clarient, Inc. Pipeline Products by Equipment Type 8
Clarient, Inc. Pipeline Products by Development Stage 10
Clarient, Inc. Pipeline Products by Therapy Area 11
Clarient, Inc. Pipeline Products by Trial Phase 13
Clarient, Inc. Pipeline Products by Milestone Summary 14
ALK PCR Test - NSCLC 16
ALK PCR Test - NSCLC Product Status 16
ALK PCR Test - NSCLC Product Description 16
ALK PCR Test - NSCLC Clinical Trial 16
Mammotax 18
Mammotax Product Status 18
Mammotax Product Description 18
Mammotax Product Milestone 18
Mammotax Product Patent Details 19
Ovatax 22
Ovatax Product Status 22
Ovatax Product Description 22
Ovatax Product Milestone 22
Ovatax Product Patent Details 23
PulmoTax 26
PulmoTax Product Status 26
PulmoTax Product Description 26
PulmoTax Product Milestone 27
Clarient, Inc. - Key Competitors 28
Clarient, Inc. - Key Employees 29
Clarient, Inc. - Key Employee Biographies 30
Clarient, Inc. - Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31

Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Table


Clarient, Inc., Key Facts 1
Clarient, Inc. Key Pipeline Products by Equipment Type 1
Clarient, Inc. Key Pipeline Products by Therapy Area 1
Clarient, Inc. Key Pipeline Products by Development Stage 1
Clarient, Inc. Key Pipeline Products by Trial Phase 1
Clarient, Inc., Key Facts 6
Clarient, Inc., Major Products and Services 7
Clarient, Inc. Number of Pipeline Products by Equipment Type 8
Clarient, Inc. Pipeline Products by Equipment Type 9
Clarient, Inc. Number of Pipeline Products by Development Stage 10
Clarient, Inc. Pipeline Products by Development Stage 10
Clarient, Inc. Number of Pipeline Products by Therapy Area 11
Clarient, Inc. Pipeline Products by Therapy Area 12
Clarient, Inc. Number of Pipeline Products by Trial Phase 13
Clarient, Inc. Pipeline Products by Trial Phase 13
Clarient, Inc. Number of Pipeline Products By Milestone Summary 14
Clarient, Inc. Pipeline Products by Milestone Summary 15
ALK PCR Test - NSCLC - Product Status 16
ALK PCR Test - NSCLC - Product Description 16
ALK PCR Test - NSCLC - Concordance Study for Detection of Chromosomal Aberrations Using FISH (ALK Test)in Non-small Cell Lung Cancer (NSCLC) 16
Mammotax - Product Status 18
Mammotax - Product Description 18
Mammotax - Product Milestone 18
Mammotax - Patent Details1 19
Mammotax - Patent Details2 20
Mammotax - Patent Details3 20
Mammotax - Patent Details4 21
Mammotax - Patent Details5 21
Ovatax - Product Status 22
Ovatax - Product Description 22
Ovatax - Product Milestone 22
Ovatax - Patent Details1 23
Ovatax - Patent Details2 23
Ovatax - Patent Details3 24
Ovatax - Patent Details4 24
Ovatax - Patent Details5 25
PulmoTax - Product Status 26
PulmoTax - Product Description 26
PulmoTax - Product Milestone 27
Clarient, Inc., Key Employees 29
Clarient, Inc., Key Employee Biographies 30
Clarient, Inc., Subsidiaries 31

List of Chart


Clarient, Inc. Pipeline Products by Equipment Type 8
Clarient, Inc. Pipeline Products by Development Stage 10
Clarient, Inc. Pipeline Products by Therapy Area 11
Clarient, Inc. Pipeline Products by Trial Phase 13
Clarient, Inc. Pipeline Products by Milestone Summary 14

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *